Introduction: This study was conducted to investigate the underlying associations between urine macrophages polarization and renal function recovery after nephron-sparing surgery (NSS) in patients with renal cell carcinoma (RCC) and to explore the potential application values of urine macrophages polarization in predicting the severity of renal ischemia/reperfusion injury (RIRI). Methods: Sixty-two patients with unilateral RCC who underwent NSS in our departments were prospectively recorded and followed up for long-term renal function to assess the onset of acute kidney injury (AKI) and chronic kidney disease (CKD). Urine samples of patients were collected 72 h after surgery for analyzing pro-inflammatory (classically activated/M1) and pro-reparative (alternatively activated/M2) macrophages polarization by flow cytometry. The detailed correlations between urine macrophages polarization and renal function recovery after NSS were explored by statistical analyses. Results: The cumulative incidence of postoperative AKI was 27.4% (17/62), and 47.0% (8/17) of those eventually developed to CKD during the follow-up. The mean urine M1/M2 ratio was 10.54 ± 8.13 in the AKI group and 3.93 ± 3.10 in the non-AKI group, presenting a significant statistical difference (p < 0.0001). Meanwhile, the urine M1/M2 ratio presented amazing potential in predicting postoperative CKD as well, with a mean ratio of 12.54 ± 9.41 in the CKD group and 4.28 ± 3.21 in the non-CKD group (p < 0.0001). Though univariate analysis implied that urine M1/M2 ratio was a relevant factor of both postoperative AKI and CKD in NSS surgical patients, multivariate analysis did not show satisfying predicting potential in postoperative CKD, mainly due to the very limited candidates enrolled in this study. Conclusion: Urine macrophages polarization could predict renal function recovery after NSS in patients with RCC. The urine M1/M2 ratio might a potential biomarker of RIRI but needs to be further verified in clinical settings.

1.
Ebbing
J
,
Menzel
F
,
Frumento
P
,
Miller
K
,
Ralla
B
,
Fuller
TF
,
Correction to: outcome of kidney function after ischaemic and zero-ischaemic laparoscopic and open nephron-sparing surgery for renal cell cancer
.
BMC Nephrol
.
2019
;
20
(
1
):
86
. .
2.
Muramaki
M
,
Miyake
H
,
Sakai
I
,
Fujisawa
M
.
Prognostic factors influencing postoperative development of chronic kidney disease in patients with small renal tumors who underwent partial nephrectomy
.
Curr Urol
.
2013
;
6
(
3
):
129
35
. .
3.
Malcolm
JB
,
Bagrodia
A
,
Derweesh
IH
,
Mehrazin
R
,
Diblasio
CJ
,
Wake
RW
,
Comparison of rates and risk factors for developing chronic renal insufficiency, proteinuria and metabolic acidosis after radical or partial nephrectomy
.
BJU Int
.
2009
;
104
(
4
):
476
81
. .
4.
Godoy
G
,
Ramanathan
V
,
Kanofsky
JA
,
O'Malley
RL
,
Tareen
BU
,
Taneja
SS
,
Effect of warm ischemia time during laparoscopic partial nephrectomy on early postoperative glomerular filtration rate
.
J Urol
.
2009
;
181
(
6
):
2438
45
; discussion 43–5 .
5.
Sorbellini
M
,
Kattan
MW
,
Snyder
ME
,
Hakimi
AA
,
Sarasohn
DM
,
Russo
P
,
Prognostic nomogram for renal insufficiency after radical or partial nephrectomy
.
J Urol
.
2006
;
176
(
2
):
472
6
; discussion 476 .
6.
Shikanov
S
,
Lifshitz
D
,
Chan
AA
,
Okhunov
Z
,
Ordonez
MA
,
Wheat
JC
,
Impact of ischemia on renal function after laparoscopic partial nephrectomy: a multicenter study
.
J Urol
.
2010
;
183
(
5
):
1714
8
. .
7.
Jeon
HG
,
Jeong
IG
,
Lee
JW
,
Lee
SE
,
Lee
E
.
Prognostic factors for chronic kidney disease after curative surgery in patients with small renal tumors
.
Urology
.
2009
;
74
(
5
):
1064
8
. .
8.
Song
C
,
Bang
JK
,
Park
HK
,
Ahn
H
.
Factors influencing renal function reduction after partial nephrectomy
.
J Urol
.
2009
;
181
(
1
):
48
53
;
discussion 53–4
.
9.
Huang
WC
,
Levey
AS
,
Serio
AM
,
Snyder
M
,
Vickers
AJ
,
Raj
GV
,
Chronic kidney disease after nephrectomy in patients with renal cortical tumours: a retrospective cohort study
.
Lancet Oncol
.
2006
;
7
(
9
):
735
40
. .
10.
Thakar
CV
,
Christianson
A
,
Himmelfarb
J
,
Leonard
AC
.
Acute kidney injury episodes and chronic kidney disease risk in diabetes mellitus
.
Clin J Am Soc Nephrol
.
2011
;
6
(
11
):
2567
72
. .
11.
Adeyemi
OA
,
Flaherty
JP
.
Emphysematous cystitis
.
Emphysematous Cystitis Cureus
.
2020
;
12
(
11
):
e11723
. .
12.
Cao
Q
,
Harris
DCH
,
Wang
Y
.
Macrophages in kidney injury, inflammation, and fibrosis
.
Physiology
.
2015
;
30
(
3
):
183
94
. .
13.
Sun
PP
,
Zhou
XJ
,
Su
JQ
,
Wang
C
,
Yu
XJ
,
Su
T
,
Urine macrophages reflect kidney macrophage content during acute tubular interstitial and glomerular injury
.
Clin Immunol
.
2019
;
205
:
65
74
. .
14.
Cho
WY
,
Choi
HM
,
Lee
SY
,
Kim
MG
,
Kim
HK
,
Jo
SK
,
The role of Tregs and CD11c(+) macrophages/dendritic cells in ischemic preconditioning of the kidney
.
Kidney Int
.
2010
;
78
(
10
):
981
92
. .
15.
Jo
SK
,
Sung
SA
,
Cho
WY
,
Go
KJ
,
Kim
HK
.
Macrophages contribute to the initiation of ischaemic acute renal failure in rats
.
Nephrol Dial Transpl
.
2006
;
21
(
5
):
1231
9
. .
16.
Lee
S
,
Huen
S
,
Nishio
H
,
Nishio
S
,
Lee
HK
,
Choi
BS
,
Distinct macrophage phenotypes contribute to kidney injury and repair
.
J Am Soc Nephrol
.
2011
;
22
(
2
):
317
26
. .
17.
Park
SW
,
Jung
SG
,
Lee
W
,
Chung
MK
.
Changes in renal function after nephron-sparing surgery in patients with a normal contralateral kidney
.
Int J Urol
.
2010
;
17
(
5
):
457
61
. .
18.
Khwaja
A
.
KDIGO clinical practice guidelines for acute kidney injury
.
Nephron Clin Pract
.
2012
;
120
(
4
):
c179
84
. .
19.
Rocco
MV
,
Gassman
JJ
,
Wang
SR
,
Kaplan
RM
.
Cross-sectional study of quality of life and symptoms in chronic renal disease patients: the modification of diet in renal disease study
.
Am J Kidney Dis
.
1997
;
29
(
6
):
888
96
. .
20.
Bonventre
JV
,
Yang
L
.
Cellular pathophysiology of ischemic acute kidney injury
.
J Clin Invest
.
2011
;
121
(
11
):
4210
21
. .
21.
Sharfuddin
AA
,
Molitoris
BA
.
Pathophysiology of ischemic acute kidney injury
.
Nat Rev Nephrol
.
2011
;
7
(
4
):
189
200
. .
22.
Venkatachalam
MA
,
Griffin
KA
,
Lan
R
,
Geng
H
,
Saikumar
P
,
Bidani
AK
,
Acute kidney injury: a springboard for progression in chronic kidney disease
.
Am J Physiol Ren Physiol
.
2010
;
298
(
5
):
F1078
94
. .
23.
Venkatachalam
MA
,
Weinberg
JM
,
Kriz
W
,
Bidani
AK
.
Failed tubule recovery, AKI-CKD transition, and kidney disease progression
.
J Am Soc Nephrol
.
2015
;
26
(
8
):
1765
76
. .
24.
Huen
SC
,
Cantley
LG
.
Macrophage-mediated injury and repair after ischemic kidney injury
.
Pediatr Nephrol
.
2015
;
30
(
2
):
199
209
. .
25.
Ye
L
,
He
S
,
Mao
X
,
Zhang
Y
,
Cai
Y
,
Li
S
,
Effect of hepatic macrophage polarization and apoptosis on liver ischemia and reperfusion injury during liver transplantation
.
Front Immunol
.
2020
;
11
:
1193
. .
26.
Dai
Y
,
Wang
S
,
Chang
S
,
Ren
D
,
Shali
S
,
Li
C
,
M2 macrophage-derived exosomes carry microRNA-148a to alleviate myocardial ischemia/reperfusion injury via inhibiting TXNIP and the TLR4/NF-κB/NLRP3 inflammasome signaling pathway
.
J Mol Cell Cardiol
.
2020
;
142
:
65
79
. .
27.
Hu
X
,
Xu
Y
,
Zhang
Z
,
Tang
Z
,
Zhang
J
,
Luo
Y
,
TSC1 affects the process of renal ischemia-reperfusion injury by controlling macrophage polarization
.
Front Immunol
.
2021
;
12
:
637335
. .
28.
Huen
SC
,
Huynh
L
,
Marlier
A
,
Lee
Y
,
Moeckel
GW
,
Cantley
LG
,
GM-CSF promotes macrophage alternative activation after renal ischemia/reperfusion injury
.
J Am Soc Nephrol
.
2015
;
26
(
6
):
1334
45
. .
29.
Yang
L
,
Brooks
CR
,
Xiao
S
,
Sabbisetti
V
,
Yeung
MY
,
Hsiao
LL
,
KIM-1-mediated phagocytosis reduces acute injury to the kidney
.
J Clin Invest
.
2015
;
125
(
4
):
1620
36
. .
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.